Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations
- 1 November 2003
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 47 (3) , 539-546
- https://doi.org/10.1016/s0732-8893(03)00119-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Daptomycin Dose-Effect Relationship against Resistant Gram-Positive OrganismsAntimicrobial Agents and Chemotherapy, 2003
- Bactericidal Activities of Two Daptomycin Regimens against Clinical Strains of Glycopeptide Intermediate-Resistant Staphylococcus aureus , Vancomycin-Resistant Enterococcus faecium , and Methicillin-Resistant Staphylococcus aureus Isolates in an In Vitro Pharmacodynamic Model with Simulated Endocardial VegetationsAntimicrobial Agents and Chemotherapy, 2001
- In Vitro Activities of Daptomycin, Arbekacin, Vancomycin, and Gentamicin Alone and/or in Combination against Glycopeptide Intermediate-Resistant Staphylococcus aureus in an Infection ModelAntimicrobial Agents and Chemotherapy, 2000
- Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection model.Journal of Antimicrobial Chemotherapy, 2000
- The Emergence of Decreased Susceptibility to Vancomycin in Staphylococcus epidermidisInfection Control & Hospital Epidemiology, 1999
- Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faeciumAntimicrobial Agents and Chemotherapy, 1992
- Daptomycin disrupts membrane potential in growing Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1991
- Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugsAntimicrobial Agents and Chemotherapy, 1991
- STAPHYLOCOCCAL SEPSIS The Changing Pattern of Disease and TherapyThe Lancet, 1988
- In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibioticAntimicrobial Agents and Chemotherapy, 1986